Horizon Therapeutics Public Ltd Co Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Horizon Therapeutics Public Ltd Co Return On Equity for the quarter ending June 30, 2023 was 8.54 %, a 47.3% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Return On Equity for 2022 was 10.5 %, a 16.3% decline from 2021.
  • Horizon Therapeutics Public Ltd Co annual Return On Equity for 2021 was 12.5 %, a 0.48% decline from 2020.
  • Horizon Therapeutics Public Ltd Co annual Return On Equity for 2020 was 12.6 %, a 62.8% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 10.5 -2.04 -16.3% Jan 1, 2022 Dec 31, 2022
2021 12.5 -0.06 -0.48% Jan 1, 2021 Dec 31, 2021
2020 12.6 -21.3 -62.8% Jan 1, 2020 Dec 31, 2020
2019 33.9 +37.5 Jan 1, 2019 Dec 31, 2019
2018 -3.65 +28.7 +88.7% Jan 1, 2018 Dec 31, 2018
2017 -32.3 -19.8 -159% Jan 1, 2017 Dec 31, 2017
2016 -12.5 -16 -456% Jan 1, 2016 Dec 31, 2016
2015 3.5 +124 Jan 1, 2015 Dec 31, 2015
2014 -120 +220 +64.7% Jan 1, 2014 Dec 31, 2014
2013 -340 -246 -262% Jan 1, 2013 Dec 31, 2013
2012 -93.9 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.